(주)안트로젠

{
  "address": "서울특별시 금천구 디지털로",
  "brno": "108812****",
  "cappedWarning": false,
  "companyName": "(주)안트로젠",
  "estimatedAvgAnnualSalary": 46675500,
  "estimatedAvgMonthlySalary": 3889625,
  "fetchedAt": "2026-03-05T19:41:38.673Z",
  "industryCode": "242301",
  "industryName": "완제 의약품 제조업",
  "joinDate": "20030101",
  "last12MonthsHired": 1,
  "last12MonthsLeft": 3,
  "last12MonthsNetChange": -2,
  "leaveDate": null,
  "monthlyPensionAmount": 11824460,
  "monthlyTrend": [
    {
      "lostSubscribers": 3,
      "newSubscribers": 1,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6640471",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 32,
  "turnoverMonths": 1
}

{
  "address": "서울특별시 금천구",
  "ceo_name": "이성구, 김미형",
  "certificate": [
    {
      "cert_number": "011135033106024",
      "changes": "",
      "disclosure_date": "2001-03-22",
      "first_cert_date": "2001-03-22",
      "no": "1",
      "type": "신기술기업(산업지원서비스업)",
      "valid_period": "2001-03-22 ~ 2003-03-21"
    },
    {
      "cert_number": "031135021200304",
      "changes": "",
      "disclosure_date": "2003-03-10",
      "first_cert_date": "2001-03-22",
      "no": "2",
      "type": "연구개발기업",
      "valid_period": "2003-03-10 ~ 2005-03-09"
    },
    {
      "cert_number": "051135021300368",
      "changes": "",
      "disclosure_date": "2005-03-10",
      "first_cert_date": "2001-03-22",
      "no": "3",
      "type": "연구개발기업",
      "valid_period": "2005-03-10 ~ 2007-03-09"
    },
    {
      "cert_number": "20070100523",
      "changes": "",
      "disclosure_date": "2007-03-16",
      "first_cert_date": "2001-03-22",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2007-03-10 ~ 2009-03-09"
    },
    {
      "cert_number": "20090106677",
      "changes": "",
      "disclosure_date": "2009-07-13",
      "first_cert_date": "2001-03-22",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2009-07-13 ~ 2011-07-12"
    },
    {
      "cert_number": "20120100688",
      "changes": "",
      "disclosure_date": "2012-02-08",
      "first_cert_date": "2001-03-22",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2012-02-08 ~ 2014-02-07"
    },
    {
      "cert_number": "20140100964",
      "changes": "",
      "disclosure_date": "2014-02-05",
      "first_cert_date": "2001-03-22",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2014-02-08 ~ 2016-02-07"
    },
    {
      "cert_number": "20160101804",
      "changes": "",
      "disclosure_date": "2016-02-29",
      "first_cert_date": "2001-03-22",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2016-02-08 ~ 2018-02-07"
    },
    {
      "cert_number": "20180102722",
      "changes": "",
      "disclosure_date": "2018-03-16",
      "first_cert_date": "2001-03-22",
      "no": "9",
      "type": "연구개발유형",
      "valid_period": "2018-02-08 ~ 2020-02-07"
    },
    {
      "cert_number": "20200105282",
      "changes": "",
      "disclosure_date": "2020-04-27",
      "first_cert_date": "2001-03-22",
      "no": "10",
      "type": "연구개발유형",
      "valid_period": "2020-02-08 ~ 2022-02-07"
    },
    {
      "cert_number": "20220302030068",
      "changes": "",
      "disclosure_date": "2022-03-02",
      "first_cert_date": "2001-03-22",
      "no": "11",
      "type": "혁신성장유형",
      "valid_period": "2022-02-08 ~ 2025-02-07"
    },
    {
      "cert_number": "20250226030021",
      "changes": "",
      "disclosure_date": "2025-02-26",
      "first_cert_date": "2001-03-22",
      "no": "12",
      "type": "혁신성장유형",
      "valid_period": "2025-02-08 ~ 2028-02-07"
    }
  ],
  "company_name": "㈜안트로젠",
  "financials": {
    "2022": {
      "capital_stock": 4865687000,
      "cost_of_sales": 3974600000,
      "current_assets": 62449414000,
      "current_liabilities": 15037067000,
      "gross_profit": 2616411000,
      "net_income": -6850064000,
      "net_income_bs": -6837098000,
      "non_current_assets": 61683299000,
      "non_current_liabilities": 2304261000,
      "non_operating_expenses": 4963880000,
      "non_operating_income": 2762029000,
      "operating_profit": -4648213000,
      "revenue": 6591011000,
      "sga_expenses": 7264624000,
      "total_assets": 124132713000,
      "total_equity": 106791385000,
      "total_liabilities": 17341328000
    },
    "2023": {
      "capital_stock": 4865687000,
      "cost_of_sales": 3833896000,
      "current_assets": 56380301000,
      "current_liabilities": 10758759000,
      "gross_profit": 2666354000,
      "net_income": -2840850000,
      "net_income_bs": -2840850000,
      "non_current_assets": 93051376000,
      "non_current_liabilities": 9227980000,
      "non_operating_expenses": 2042772000,
      "non_operating_income": 4275765000,
      "operating_profit": -5073843000,
      "revenue": 6500250000,
      "sga_expenses": 7740197000,
      "total_assets": 149431677000,
      "total_equity": 129444937000,
      "total_liabilities": 19986740000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "phone": "02-2104-****",
  "source": "pg_migration"
}